Negotiation of License for Patented Medical Technology and Venture Capital Financing


The founders of a drug discovery company turned to Larkin Hoffman for counsel for initial formation and negotiating a license with a major university for patented technology developed to combat hemorrhagic shock. The Larkin Hoffman team, led by Frank Harvey, also negotiated for the newly formed company in obtaining venture capital financing to fund the development and necessary approvals to market the drug.